Insertion of Different Supraglottic Airway Devices on Manikin

August 29, 2022 updated by: Keziban Bollucuoglu, Zonguldak Bulent Ecevit University

Placement of Four Different Supraglottic Airway Devices by Medicine Faculty Students: A Manikin Study

When tracheal intubation and face mask ventilation fail, and the insertion of supraglottic airway devices (SHA) can provide ventilation, protecting the patient from hypoxemia. Supraglottic airway devices have become an important part of difficult airway algorithms. The European Resuscitation Council Guidelines recommend supraglottic airway devices for airway management by non-specialized healthcare providers. Education through simulators contributes to the development of students without direct contact with patients. In this study, it was aimed to compare the success of placement of four different supraglottic airway devices on the manikin of term 5 students who participate to the Anesthesiology and Reanimation internship.

Study Overview

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kozlu
      • Zonguldak, Kozlu, Turkey, 67600
        • Zonguldak Bülent Ecevit University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Studying in medical school in term 5
  • To have completed anesthesiology and reanimation internship

Exclusion Criteria:

  • who do not want to participate in the study
  • Students with previous experience with four airway devices

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Proseal Laryngeal Mask
insertion of Proseal Laryngeal Mask
Other: Classic Laryngeal Mask
insertion of Classic Laryngeal Mask
Other: I-gel
insertion of I-gel
Other: Suprema Laryngeal Mask
insertion of Suprema Laryngeal Mask

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
difficulty of attempts
Time Frame: during insertion procedure
pointing the difficulty of insertion from 0 to 100
during insertion procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of attempts
Time Frame: during insertion procedure
time from insertion to ventilation
during insertion procedure
number of attempts
Time Frame: during insertion procedure
number of attempts for successfull placement
during insertion procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

July 30, 2022

Study Completion (Actual)

August 15, 2022

Study Registration Dates

First Submitted

August 16, 2022

First Submitted That Met QC Criteria

August 29, 2022

First Posted (Actual)

August 31, 2022

Study Record Updates

Last Update Posted (Actual)

August 31, 2022

Last Update Submitted That Met QC Criteria

August 29, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2022/03-13

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilation

Clinical Trials on Proseal Laryngeal Mask

Subscribe